scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0031-9422(00)82287-6 |
P2093 | author name string | Hiroji Sato | |
Sadao Sakamura | |||
Tsuyoshi Nishitoba | |||
P2860 | cites work | Useful procedures for the oxidation of alcohols involving pyridinium dichromate in aprotic media | Q55980156 |
The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes | Q68942535 | ||
Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes fromGanoderma lucidum (FR.) KARST. | Q78234437 | ||
Ganoderic acid D, E, F, and H and lucidenic acid D, E, and F, new triterpenoids from Ganoderma lucidum. | Q78435470 | ||
Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum. | Q78435475 | ||
Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae). | Q78435485 | ||
New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). | Q78436255 | ||
Les acides ganoderiques tàz : triterpenes cytotoxiques de Ganoderma lucidum (Polyporacée) | Q103817435 | ||
Evidence on the strain-specific terpenoid pattern of Ganoderma lucidum. | Q104388990 | ||
Ganoderic acid derivatives, highly oxygenated lanostane-type triterpenoids, from Ganoderma lucidum | Q104884511 | ||
A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum | Q104886658 | ||
New terpenoids from Ganoderma lucidum and their bitterness. | Q104913401 | ||
New terpenoids, ganoderic acid J and ganolucidic acid C, from the fungus Ganoderma lucidum. | Q104963896 | ||
New terpenoids, ganolucidic acid D, ganoderic acid L, lucidone C and lucidenic acid G, from the fungus Ganoderma lucidum. | Q115950950 | ||
New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). | Q120073746 | ||
P433 | issue | 6 | |
P921 | main subject | Ganoderma lucidum | Q271098 |
lucidenic acid e | Q27896431 | ||
Ganoderic acid N | Q77494945 | ||
Ganoderic Acid C2 | Q104196528 | ||
(2r,6s)-6-[(3s,5r,10s,12s,13r,14r,17r)-12-Acetoxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid | Q104886532 | ||
methyl (4R)-4-[(3S,4R,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4-(hydroxymethyl)-4,10,13,14-tetramethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate | Q104938268 | ||
(4R)-4-[(3S,5R,10S,12S,13R,14R,17R)-3,12-dihydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid | Q104970696 | ||
(3beta,5alpha,7alpha,15alpha)-3,7,15-Trihydroxy-4,4,14-trimethyl-11-oxochol-8-en-24-oic acid | Q104986675 | ||
3beta,7beta,28-Trihydroxy-11,15-dioxo-25,26,27-trinorlanosta-8-ene-24-oic acid | Q105003745 | ||
(4R)-4-[(3S,4R,5R,10S,12S,13R,14R,17R)-3,12-dihydroxy-4-(hydroxymethyl)-4,10,13,14-tetramethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid | Q105025094 | ||
methyl (2R,6R)-6-[(3S,5R,10S,13R,14R,15S,17R)-3,15-dihydroxy-4,4,10,13,14-pentamethyl-7,11-dioxo-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate | Q105032582 | ||
methyl (2R,6R)-6-[(3S,5R,10S,12S,13R,14R,17R)-12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate | Q105147601 | ||
(2R,6R)-6-[(5S,7S,10S,12R,13R,14S,17S)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid | Q105149849 | ||
methyl (E,2R)-6-[(5R,7S,10S,12S,13R,14R,17R)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoate | Q105151866 | ||
(4R)-4-[(5R,10S,12S,13R,14R,17R)-12-hydroxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | Q105177183 | ||
methyl lucidenate L | Q105179092 | ||
6-[(3R,7R,10R,12R,13S,14S)-12-acetyloxy-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid | Q105190285 | ||
methyl (4R)-4-[(3S,5R,7R,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pentanoate | Q105213182 | ||
methyl (2R,6S)-6-hydroxy-6-[(5R,7S,10S,13R,14R,17S)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate | Q105229221 | ||
(2S,6S)-6-hydroxy-2-methyl-4-oxo-6-[(5S,10S,13R,14S,17S)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid | Q105229508 | ||
methyl (2R,6S)-6-hydroxy-2-methyl-4-oxo-6-[(5R,10S,13R,14R,17S)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoate | Q105270811 | ||
methyl (2R,6R)-2-methyl-4-oxo-6-[(3S,5R,7R,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptanoate | Q105270837 | ||
methyl (4R)-4-[(3S,4R,5R,10S,12S,13R,14R,17R)-3,12-dihydroxy-4-(hydroxymethyl)-4,10,13,14-tetramethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoate | Q105276097 | ||
Chol-8-en-24-oic acid, 3-hydroxy-4-(hydroxymethyl)-4,14-dimethyl-7,11,15-trioxo-, (3beta,4alpha,5alpha)- | Q105287271 | ||
methyl (4R)-4-[(5R,10S,12R,13R,14R,17R)-12-hydroxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate | Q105303510 | ||
methyl (2R,6S)-6-[(5R,7S,10S,12R,13R,14R,17S)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoate | Q105327615 | ||
(E,6R)-6-[(3S,5R,10S,13R,14R,15S,17R)-15-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid | Q105346548 | ||
methyl (4R)-4-[(3S,4R,5R,10S,13R,14R,17R)-3-hydroxy-4-(hydroxymethyl)-4,10,13,14-tetramethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoate | Q105352976 | ||
Ganoderenic-acid-E | Q110188307 | ||
17-acetyl-4,4,10,13,14-pentamethyl-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthrene-3,7,11,15-tetrone | Q115946595 | ||
P1104 | number of pages | 8 | |
P304 | page(s) | 1777-1784 | |
P577 | publication date | 1987-01-01 | |
P1433 | published in | Phytochemistry | Q1884753 |
P1476 | title | Triterpenoids from the fungus Ganoderma lucidum | |
P478 | volume | 26 |
Q31431980 | Constituents of various wood-rotting basidiomycetes |
Q36944240 | Ganoderma lucidum and its pharmaceutically active compounds |
Q103817466 | Lanostanoid triterpenes from Ganoderma applanatum |
Q36371955 | Medicinal Benefits of the Mushroom Ganoderma |
Search more.